GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro were initially developed to treat type 2 diabetes, but their effectiveness as anti-obesity medications has generated tremendous excitement and high demand among people who have struggled to lose weight by other means
Weight loss
Remember that unlike FSAs, HSA funds roll over year to year, offering more flexibility in saving for ongoing medication costs
This paper adds to growing evidence that GLP-1 receptor agonists may have an oncologic impact by improving metabolic health, said Paunel Vukasinov, MD, a dual board certified internist and obesity medicine specialist at Medical Offices of Manhattan
Through this new offering, Noom members will be evaluated by board-certified physicians with expertise in obesity and weight loss to qualify for the weight loss medication
Microdosing GLP-1 medications has become a trending practice nowadays, promoted by some clinics, social media and online communities to individuals who want only modest weight reduction or who are trying to stretch prescriptions because of high drug prices and supply shortages